Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.